LASIK Should Carry Warnings of Possible Complications, FDA Says
New guidance says complications can include dry eyes, double vision, difficulty with night driving, chronic eye pain
Diagnosis & Disease Information
October 2022 Recap: Drug Pipeline Updates
The table provided is a review of notable updates that occurred in October 2022 for investigational products in development.
FDA to Review Novel Cyclosporine Ophthalmic Solution for Dry Eye Disease
CyclASol is an investigational topical treatment of cyclosporine that contains no oils or surfactants and is preservative-free.
FDA to Review Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease
NOV03 is an investigational, water- and preservative-free nonsteroidal eye drop.
First Generic Version of Restasis Gets FDA Approval
Cyclosporine ophthalmic emulsion is indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
October 2021: 5 Notable Drug Approvals
Review the October 2021 notable drug approvals.
Tyrvaya Nasal Spray Now Available for Dry Eye Disease
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
MPR Weekly Dose Podcast Episode 97
This week: The FDA authorize boosters for Moderna and Janssen and okay ‘mixing and matching’ of vaccines for the booster dose. The first interchangeable biosimilar to Humira is approved. Also there’s approvals in dry eye disease, pain management and opioid overdoses.
Tyrvaya Nasal Spray Approved for Dry Eye Disease
Tyrvaya contains varenicline, a highly selective nicotinic acetylcholine agonist.
Systane Hydration Multi-Dose Preservative-Free Formulation Now Available
The over-the-counter product may be used as a protectant against further eye irritation and to relieve dryness of the eye.
